A motivação para a realização deste artigo foi a percepção de que o movimento de preços dos imóveis em Natal apresentava componentes que precisavam ser investigados, notadamente o influxo de capital estrangeiro, sobretudo para aplicação nos setores de turismo e imobiliário e o comportamento do crédito imobiliário. O objetivo do trabalho é examinar a evolução dos preços no mercado de imóveis da cidade no período 2005; 2010. Os indicadores levantados permitiram uma coleta de evidências suficiente para ampliar o grau de confiança nas hipóteses de que, de fato: a) ocorreu uma bolha no mercado de imóveis no triênio 2005; 2007; b) a bolha não implodiu no biênio 2009; 2010, após a crise financeira de 2008, pois o movimento de alta de preços se manteve tanto nos imóveis vendidos na planta quanto nos imóveis prontos.

This study aimed to evaluate the efficacy and toxicity of tenofovir (TDF) and TDF combined with emtricitabine (TDF/FTC) in patients with mild to moderate COVID-19 infections. We conducted a randomized, double-blind, placebo-controlled clinical trial in patients with clinical suspicion of mild to moderate respiratory infection caused by SARS-CoV-2 who were treated at an outpatient clinic. Patients were randomly recruited to take 10 days of TDF (300 mg/day), TDF (300 mg/day) combined with FTC (200 mg/day) or placebo Vitamin C (500 mg/day). The primary parameter was the score of symptoms and predictive signs of COVID-19, assessed on the seventh day of patient follow-up. From a total of 309 patients with clinical suspicion of SARS-CoV-2, 227 met the inclusion criteria and were randomly distributed into the following groups: (a) 75 (one did not initiate treatment) in the TDF group; (b) 74 in the TDF combined with FTC group; and (c) 77 in the Vitamin C group (placebo). Of the 226 patients, 139 (62%) were positive for SARS-CoV-2. Fever (37.8oC), ageusia or dysgeusia, anosmia or dysosmia, and two or more clinical symptoms or signs were significantly associated with SARS-CoV-2 infection. There was no significant change in clinical score based on clinical symptoms and signs between treatment groups. Patients with mild to moderate infection by SARS-CoV-2 had higher concentrations of G-CSF, IL-1β, IL-6 and TNF-α compared to patients without infection. Patients with mild to moderate respiratory infection, with fever (37.8oC), loss of smell, loss of taste and two or more symptoms, have a better prediction for the diagnosis of COVID-19. Patients with SARS-CoV-2 showed higher and more persistent proinflammatory cytokines profile compared to patients not infected with SARS-CoV-2. Pharmacological intervention with TDF or TDF combined with FTC did not change the clinical signs and symptoms score in mild to moderate respiratory infection in patients with SARS-CoV-2 compared to the Vitamin C group (placebo).

Worldwide, the COVID-19 has generated multiple challenges, requiring responses that can effectively make the sustained decline in disease growth levels, and thereby prevent the collapse of health systems. The purpose of this paper is to discuss how the Northeast region of Brazil (NEB) has been building capacity to respond in an innovative and articulated way to the challenges of the pandemic in its territories. This is an essay, based on documentary research and secondary data, collected from state institutional sources and other Brazilian official bodies. The results allow us to conclude that in the NEB these responses are being conducted in an articulated way considering interfaces between social vulnerability, governance and innovation.

No abstract